Biocept reported $-2707000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 2478M 434M
Becton, Dickinson and BDX:US $ 648M 157M
Biocept BIOC:US $ -2707000 68.54K
Celldex Therapeutics CLDX:US $ -21396000 1.86M
Cerulean Pharma CERU:US $ -8400450 1.14M
Cytori Therapeutics CYTX:US $ -5120000 1.19M
General Electric GE:US $ 1090M 587M
Illumina ILMN:US $ 30M 154M
Quest Diagnostics DGX:US $ 388M 137M
Thermo Fisher Scientific TMO:US $ 2025M 798M